MML Investors Services
IHE icon

MML Investors Services’s iShares US Pharmaceuticals ETF IHE Stock Holding History

MML Investors Services’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$912K Buy
9,211
+6,071
+193% +$547K ﹤0.01% 2068
2026
Q1 		$272K Sell
3,140
-410
-12% -$35.9K ﹤0.01% 2627
2025
Q4 		$301K Buy
3,550
+63
+2% +$5.03K ﹤0.01% 2625
2025
Q3 		$253K Sell
3,487
-1,128
-24% -$77.8K ﹤0.01% 2633
2025
Q2 		$302K Buy
4,615
+1,328
+40% +$86.4K ﹤0.01% 2425
2025
Q1 		$232K Buy
3,287
+230
+8% +$16K ﹤0.01% 2456
2024
Q4 		$201K Sell
3,057
-48
-2% -$3.3K ﹤0.01% 2521
2024
Q3 		$219K Sell
3,105
-136
-4% -$9.48K ﹤0.01% 2385
2024
Q2 		$215K Buy
3,241
+248
+8% +$16.3K ﹤0.01% 2306
2024
Q1 		$203K Buy
+2,993
New +$198K ﹤0.01% 2352
2023
Q2 		– Sell
-3,615
Closed -$211K – 2320
2023
Q1 		$211K Buy
+3,615
New +$218K ﹤0.01% 1883
2022
Q3 		– Sell
-3,300
Closed -$211K – 2111
2022
Q2 		$211K Sell
3,300
-12
-0.4% -$762 ﹤0.01% 1875
2022
Q1 		$214K Sell
3,312
-45
-1% -$2.85K ﹤0.01% 1922
2021
Q4 		$223K Sell
3,357
-276
-8% -$17.5K ﹤0.01% 1867
2021
Q3 		$222K Buy
3,633
+48
+1% +$3.05K ﹤0.01% 1818
2021
Q2 		$222K Buy
3,585
+72
+2% +$4.38K ﹤0.01% 1775
2021
Q1 		$208K Buy
3,513
+60
+2% +$3.62K ﹤0.01% 1711
2020
Q4 		$206K Buy
+3,453
New +$197K ﹤0.01% 1584
2019
Q1 		– Sell
-5,697
Closed -$267K – 1614
2018
Q4 		$267K Sell
5,697
-2,253
-28% -$115K ﹤0.01% 1224
2018
Q3 		$445K Buy
7,950
+3,405
+75% +$186K 0.01% 1056
2018
Q2 		$229K Sell
4,545
-4,104
-47% -$203K 0.01% 1205
2018
Q1 		$425K Sell
8,649
-10,209
-54% -$524K 0.01% 910
2017
Q4 		$970K Sell
18,858
-53,391
-74% -$2.74M 0.02% 557
2017
Q3 		$3.77M Sell
72,249
-32,403
-31% -$1.66M 0.08% 214
2017
Q2 		$5.41M Buy
+104,652
New +$5.29M 0.1% 168

Other funds holding IHE

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
IWS
Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return
MCM
Monument Capital Management Alexandria, Virginia $497M AUM 52.58% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return
AWM
Accurate Wealth Management Wesley Chapel, Florida $1.05B AUM 30.92% 1-Year Est. Return
FP
FFG Partners Fort Lauderdale, Florida $352M AUM 70.53% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

MML Investors Services's IHE Position: Q2 2026 in Review

MML Investors Services increased its iShares US Pharmaceuticals ETF (IHE) stake by 193% in Q2 2026, buying an estimated $547K and bringing the position to 9,211 shares worth $912K. The position accounts for ﹤0.01% of the portfolio, ranked #2068.

MML Investors Services first reported a position in IHE in Q2 2017 and has held it in 25 quarters since. The position peaked at $5.41M in Q2 2017. 120 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

  • MML Investors Services held 9,211 shares of iShares US Pharmaceuticals ETF worth $912K as of Q2 2026.
  • MML Investors Services bought 6,071 iShares US Pharmaceuticals ETF shares in Q2 2026, an estimated $547K.
  • iShares US Pharmaceuticals ETF made up ﹤0.01% of MML Investors Services's portfolio in Q2 2026, its #2068 holding.
  • MML Investors Services first reported a position in iShares US Pharmaceuticals ETF in Q2 2017 and has held it in 25 quarters since.
  • MML Investors Services's iShares US Pharmaceuticals ETF position peaked at $5.41M in Q2 2017.
  • 120 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.